OBJECTIVE: To examine the association of baseline and lifetime ethanol intake with cancer of the pancreas in the European Prospective Investigation into Cancer and Nutrition (EPIC). METHODS: Included in this analysis were 478,400 subjects, of whom detailed information on the intake of alcoholic beverages at baseline and over lifetime was collected between 1992 and 2000. During a median follow-up time of 8.9 years, 555 non-endocrine pancreatic cancer cases were observed. Multivariate Cox proportional hazard models were used to examine the association of ethanol intake at recruitment and average lifetime ethanol intake and pancreatic cancer adjusting for smoking, height, weight, and history of diabetes. RESULTS: Overall, neither ethanol intake at recruitment (relative risk (RR) = 0.94, 95% confidence interval (CI) 0.69-1.27 comparing 30+ g/d vs. 0.1-4.9 g/d) nor average lifetime ethanol intake (RR = 0.95, 95% CI 0.65-1.39) was associated with pancreatic cancer risk. High lifetime ethanol intake from spirits/liquor at recruitment tended to be associated with a higher risk (RR = 1.40, 95% CI 0.93-2.10 comparing 10+ g/d vs. 0.1-4.9 g/d), but no associations were observed for wine and beer consumption. CONCLUSION: These results suggest no association of alcohol consumption with the risk of pancreatic cancer.
OBJECTIVE: To examine the association of baseline and lifetime ethanol intake with cancer of the pancreas in the European Prospective Investigation into Cancer and Nutrition (EPIC). METHODS: Included in this analysis were 478,400 subjects, of whom detailed information on the intake of alcoholic beverages at baseline and over lifetime was collected between 1992 and 2000. During a median follow-up time of 8.9 years, 555 non-endocrine pancreatic cancer cases were observed. Multivariate Cox proportional hazard models were used to examine the association of ethanol intake at recruitment and average lifetime ethanol intake and pancreatic cancer adjusting for smoking, height, weight, and history of diabetes. RESULTS: Overall, neither ethanol intake at recruitment (relative risk (RR) = 0.94, 95% confidence interval (CI) 0.69-1.27 comparing 30+ g/d vs. 0.1-4.9 g/d) nor average lifetime ethanol intake (RR = 0.95, 95% CI 0.65-1.39) was associated with pancreatic cancer risk. High lifetime ethanol intake from spirits/liquor at recruitment tended to be associated with a higher risk (RR = 1.40, 95% CI 0.93-2.10 comparing 10+ g/d vs. 0.1-4.9 g/d), but no associations were observed for wine and beer consumption. CONCLUSION: These results suggest no association of alcohol consumption with the risk of pancreatic cancer.
Authors: R Z Stolzenberg-Solomon; P Pietinen; M J Barrett; P R Taylor; J Virtamo; D Albanes Journal: Am J Epidemiol Date: 2001-04-01 Impact factor: 4.897
Authors: David N Criddle; Michael G T Raraty; John P Neoptolemos; Alexei V Tepikin; Ole H Petersen; Robert Sutton Journal: Proc Natl Acad Sci U S A Date: 2004-07-09 Impact factor: 11.205
Authors: E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci Journal: Public Health Nutr Date: 2002-12 Impact factor: 4.022
Authors: Sarah T Ward; Surabhi Dangi-Garimella; Mario A Shields; Brett A Collander; Mohammed A Q Siddiqui; Seth B Krantz; Hidayatullah G Munshi Journal: J Cell Biochem Date: 2011-10 Impact factor: 4.429
Authors: Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari Journal: World J Gastroenterol Date: 2011-02-21 Impact factor: 5.742
Authors: E Lucenteforte; C La Vecchia; D Silverman; G M Petersen; P M Bracci; B T Ji; C Bosetti; D Li; S Gallinger; A B Miller; H B Bueno-de-Mesquita; R Talamini; J Polesel; P Ghadirian; P A Baghurst; W Zatonski; E Fontham; W R Bamlet; E A Holly; Y T Gao; E Negri; M Hassan; M Cotterchio; J Su; P Maisonneuve; P Boffetta; E J Duell Journal: Ann Oncol Date: 2011-05-02 Impact factor: 32.976
Authors: Michelle A Anderson; Eugene Zolotarevsky; Kristine L Cooper; Simon Sherman; Oleg Shats; David C Whitcomb; Henry T Lynch; Paola Ghiorzo; Wendy S Rubinstein; Kristen J Vogel; Aaron R Sasson; William E Grizzle; Marsha A Ketcham; Shih-Yuan Lee; Daniel Normolle; Caitlyn M Plonka; Amy N Mertens; Renee C Tripon; Randall E Brand Journal: Am J Gastroenterol Date: 2012-08-28 Impact factor: 10.864
Authors: Sabine Naudin; Kuanrong Li; Tristan Jaouen; Nada Assi; Cecilie Kyrø; Anne Tjønneland; Kim Overvad; Marie-Christine Boutron-Ruault; Vinciane Rebours; Anne-Laure Védié; Heiner Boeing; Rudolf Kaaks; Verena Katzke; Christina Bamia; Androniki Naska; Antonia Trichopoulou; Franco Berrino; Giovanna Tagliabue; Domenico Palli; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Petra H Peeters; H B As Bueno-de-Mesquita; Elisabete Weiderpass; Inger Torhild Gram; Guri Skeie; Maria-Dolores Chirlaque; Miguel Rodríguez-Barranco; Aurelio Barricarte; Jose Ramón Quirós; Miren Dorronsoro; Ingegerd Johansson; Malin Sund; Hanna Sternby; Kathryn E Bradbury; Nick Wareham; Elio Riboli; Marc Gunter; Paul Brennan; Eric J Duell; Pietro Ferrari Journal: Int J Cancer Date: 2018-03-30 Impact factor: 7.396